EANS-Adhoc: The Management Board of CompuGroup Medical AG decides share buyback
--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------
09.07.2012
The Management Board of CompuGroup Medical AG, Koblenz, ISIN DE0005437305 (the
company), in accordance with Section 71 (1) 8 of the German Stock Corporation
Act (Aktiengesetz), decided on July 9th, 2012 to make use of the authorization
to buy back shares of the company granted by the shareholders at the annual
general meeting on May 19th 2010.
Up to 1,000,000 shares of the company will be repurchased, corresponding to
approximately 1.88 percent of the company's share capital.
The repurchased shares can be used for all purposes covered by the
authorization of the annual general meeting.
Shares will be repurchased exclusively through the XETRA trade of Deutsche
Börse AG (Frankfurt Stock Exchange). The share buyback will be conducted in
compliance with the terms of trade detailed in Article 5 of Commission
Regulation (EC) No. 2273/2003 of December 22, 2003.
The price the company pays per share is not allowed to exceed ten per cent more
or less than the stock market price. The authoritative stock market price in
this context is the non-weighted average price of the company's share which is
determined by the closing auction in XETRA trading at Frankfurt Stock Exchange
on the last five stock exchange trading days before the day when the shares are
acquired. In addition to this, the shares will not be acquired at prices that
are above the last independently made sale or, if it is higher, the last
independent offer to buy the shares in XETRA trading at Frankfurt Stock
Exchange.
The share buyback will be executed by a credit institute which will decide on
the time of the share's purchase independently and uninfluenced by the company.
The share buyback will commence from July 9th 2012and will end April 30th ,
2015 at the latest. The company's Management Board can decide to terminate the
share buyback early at any time.
Further inquiry note:
Ralf Glass
Vicepresident CEO support
T +49 (0) 160 3630315
E-Mail: ralf.glass@cgm.com
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: CompuGroup Medical AG
Maria Trost 21
D-56070 Koblenz
phone: +49 (0) 261 8000-0
FAX: +49 (0) 261 8000-1166
mail: investor@cgm.com
WWW: www.cgm.com
sector: Software
ISIN: DE0005437305
indexes:
stockmarkets: free trade: Berlin, München, Hamburg, Düsseldorf, Stuttgart,
regulated dealing/prime standard: Frankfurt
language: English